Christian Philipp Selinger (Christian Selinger, Christian P Selinger, C P Selinger)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 76

Top Topics

Systematic Review

Patients With Inflammatory Bowel Disease

Top Venues

Alimentary pharmacology & therapeutics

Journal of clinical medicine

BMJ open gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Philipp Selinger, Alex Bottle, Christopher Andrew Lamb, Rachel Ainley, Ruth Wakeman, Barney Hawthorne
Evaluation of emergency hospital admissions for inflammatory bowel disease as a possible marker of quality of care of British IBD inflammatory bowel disease units. Frontline gastroenterology 15 (3) (2024)
Christian Philipp Selinger, Samantha Baillie, Richard C G Pollok
Letter: Addressing opioid exposure and associated harms in patients with IBD. Alimentary pharmacology & therapeutics 60 (3) (2024)
Christian Philipp Selinger, Samantha Baillie, Richard C G Pollok
Letter: Addressing opioid exposure and associated harms in patients with IBD. Alimentary pharmacology & therapeutics 60 (3) (2024)
Melanie Cuffe, Christian Philipp Selinger
IBD in women of reproductive age: where do novel therapies fit in? Expert review of gastroenterology & hepatology (2024)
Christian Philipp Selinger, Konstantina Rosiou, Marco V Lenti
Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment? BMJ open gastroenterology 11 (1) (2024)
Melanie Cuffe, Christian Philipp Selinger
IBD in women of reproductive age: where do novel therapies fit in? Expert review of gastroenterology & hepatology 18 (4-5) (2024)
Christian Philipp Selinger
Risk of developing IBD in high-risk individuals: the need to study the exposome more. Gut (2024)
Christian Philipp Selinger, Konstantina Rosiou, Marco V Lenti
Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment? BMJ open gastroenterology 11 (1) (2024)
Melanie Cuffe, Christian Philipp Selinger
IBD in women of reproductive age: where do novel therapies fit in? Expert review of gastroenterology & hepatology (2024)
Christian Philipp Selinger, Konstantina Rosiou, Marco V Lenti
Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment? BMJ open gastroenterology 11 (1) (2024)
Christian Philipp Selinger, Andrea van der Meulen
Current Status, Challenges, and Future Directions in Crohn's Disease. Journal of clinical medicine 13 (16) (2024)
Christian Philipp Selinger, Andrea van der Meulen
Current Status, Challenges, and Future Directions in Crohn's Disease. Journal of clinical medicine 13 (16) (2024)
Christian Philipp Selinger, Samantha Baillie, Richard C G Pollok
Letter: Addressing opioid exposure and associated harms in patients with IBD. Alimentary pharmacology & therapeutics (2024)
Christian Philipp Selinger, Konstantina Rosiou, Marco V Lenti
Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment? BMJ open gastroenterology 11 (1) (2024)
Christian Philipp Selinger, Konstantina Rosiou, Marco V Lenti
Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment? BMJ open gastroenterology 11 (1) (2024)
Christian Philipp Selinger, Alex Bottle, Christopher Andrew Lamb, Rachel Ainley, Ruth Wakeman, Barney Hawthorne
Evaluation of emergency hospital admissions for inflammatory bowel disease as a possible marker of quality of care of British IBD inflammatory bowel disease units. Frontline gastroenterology 15 (3) (2024)
Isabel Carbery, Gemma Burdge, Tanya Clark, Giacomo Broglio, Dan Greer, Alaa Alakkari, Christian Philipp Selinger
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13). BMJ open gastroenterology 10 (1) (2023)
Isabel Carbery, Gemma Burdge, Tanya Clark, Giacomo Broglio, Dan Greer, Alaa Alakkari, Christian Philipp Selinger
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13). BMJ open gastroenterology 10 (1) (2023)
Niloufar Monfared, Matthew Gold, Isabel Carbery, Robyn Laube, Christian Philipp Selinger
Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review. Journal of clinical medicine 13 (1) (2023)
Christian Philipp Selinger, Robyn Laube, Helen Steed, Matthew Brookes, Nihr BioResource, Rupert W L Leong
Planning to conceive within a year is associated with better pregnancy-specific disease-related patient knowledge and better medication adherence in women of childbearing age with inflammatory bowel disease. Therapeutic advances in gastroenterology 16 (2023)
Christian Philipp Selinger, Helen Steed, Satvinder Purewal, Rebecca Homer, null Nihr BioResource, Matthew James Brookes
Factors Associated with Family Planning Status and Voluntary Childlessness in Women of Childbearing Age with Inflammatory Bowel Diseases. Journal of clinical medicine 12 (13) (2023)
Konstantina Rosiou, Christian Philipp Selinger
Obstetric Considerations in Pregnant Women with Crohn's Disease. Journal of clinical medicine 12 (2) (2023)
Konstantina Rosiou, Christian Philipp Selinger
Obstetric Considerations in Pregnant Women with Crohn's Disease. Journal of clinical medicine 12 (2) (2023)
Isabel Carbery, Gemma Burdge, Tanya Clark, Giacomo Broglio, Dan Greer, Alaa Alakkari, Christian Philipp Selinger
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13). BMJ open gastroenterology 10 (1) (2023)
Niloufar Monfared, Matthew Gold, Isabel Carbery, Robyn Laube, Christian Philipp Selinger
Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review. Journal of clinical medicine 13 (1) (2023)
Isabel Carbery, Gemma Burdge, Tanya Clark, Giacomo Broglio, Dan Greer, Alaa Alakkari, Christian Philipp Selinger
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13). BMJ open gastroenterology 10 (1) (2023)
Konstantina Rosiou, Christian Philipp Selinger
Obstetric Considerations in Pregnant Women with Crohn's Disease. Journal of clinical medicine 12 (2) (2023)
Christian Philipp Selinger, Robyn Laube, Helen Steed, Matthew Brookes, Nihr BioResource, Rupert W L Leong
Planning to conceive within a year is associated with better pregnancy-specific disease-related patient knowledge and better medication adherence in women of childbearing age with inflammatory bowel disease. Therapeutic advances in gastroenterology 16 (2023)
Robyn Laube, Christian Philipp Selinger, Cynthia H-T Seow, Britt Christensen, Emma K Flanagan, Debra Kennedy, Reme Mountifield, Sean K M Seeho, Antonia W Shand, Astrid-Jane Williams, Rupert W L Leong
Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding. Gut (2023)
Konstantina Rosiou, Christian Philipp Selinger
Obstetric Considerations in Pregnant Women with Crohn's Disease. Journal of clinical medicine 12 (2) (2023)
Gemma Burdge, Alice Hardman, Isabel Carbery, Giacomo Broglio, Dan Greer, Christian Philipp Selinger
Uptake of a Switching Program for Patients Receiving Intravenous Infliximab and Vedolizumab to Subcutaneous Preparations. Journal of clinical medicine 11 (19) (2022)
Christian Philipp Selinger, Klaartje Bel Kok, Jimmy K Limdi, Alexandra Kent, Rachel Cooney, Catherine Nelson-Piercy
Live vaccinations for infants exposed to maternal infliximab in utero and via breast milk - the need for nuanced decision making. BMJ open gastroenterology 9 (1) (2022)
Antonia Md Churchhouse, Victoria El Moffat, Christian Philipp Selinger, Christopher Andrew Lamb, Michelle J Thornton, Ian D Penman, Shahida Din, null null, null null
British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance. Gut 72 (9) (2022)
Charlie W Lees, Tariq Ahmad, Christopher Andrew Lamb, Nick Powell, Shahida Din, Rachel Cooney, Nicholas A Kennedy, Rachel Ainley, Ruth Wakeman, Christian Philipp Selinger
Withdrawal of the British Society of Gastroenterology IBD risk grid for COVID-19 severity. Gut (2022)
Neil Chanchlani, Simeng Lin, Marcus Karl-Heinz Auth, Chai Leng Lee, Helena Robbins, Shi Looi, Senthil V Murugesan, Tom Riley, Cathryn Preston, Sophie Stephenson, Wendy Cardozo, Sunil A Sonwalkar, Mohammed Allah-Ditta, Lynne Mansfield, Dharmaraj Durai, Mark Baker, Ian London, Emily London, Sanjay Gupta, Alex Di Mambro, Aisling Murphy, Edward Gaynor, Kelsey D J Jones, Andrew Claridge, Shaji Sebastian, Sankaranarayanan Ramachandran, Christian Philipp Selinger, Simon P Borg-Bartolo, Paul Knight, Michael B Sprakes, Julie Burton, Patricia Kane, Stephanie Lupton, Aimee Fletcher, Daniel R Gaya, Roghan Colbert, John Paul Seenan, Jonathan Macdonald, Lucy Lynch, Iain McLachlan, Stephanie Shields, Richard Hansen, Lisa Gervais, Mwansa Jere, Muhammad Akhtar, Karen Black, Paul Henderson, Richard Kay Russell, Charlie W Lees, Lauranne A A P Derikx, Melanie Lockett, Frederica Betteridge, Aminda De Silva, Arif Hussenbux, John Beckly, Oliver Bendall, James W Hart, Amanda Thomas, Benjamin Hamilton, Claire Gordon, Desmond Chee, Timothy James McDonald, Rachel Nice, Marian Parkinson, Helen Gardner-Thorpe, Jeff R Butterworth, Asima Javed, Sarah Al-Shakhshir, Rekha Yadagiri, Sebrene Maher, Richard C G Pollok, Tze Ng, Priscilla Appiahene, Fiona Donovan, James Lok, Rajiv Chandy, Reema Jagdish, Daniyal Baig, Zahid Mahmood, Liane Marsh, Allison Moss, Amin Abdulgader, Angus Kitchin, Gareth J Walker, Becky George, Yuen-Hui Lim, James Gulliver, Stuart Bloom, Holly Theaker, Sean Carlson, J R Fraser Cummings, Robert Livingstone, Amanda Beale, Josiah O Carter, Andrew Bell, Archibald Coulter, Jonathon Snook, Helen Stone, Nicholas Alexander Kennedy, James R Goodhand, Tariq Ahmad, null null
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study. Alimentary pharmacology & therapeutics 56 (8) (2022)
Konstantina Rosiou, Christian Philipp Selinger
Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease-authors' reply. Alimentary pharmacology & therapeutics 56 (5) (2022)
Marc Ferrante, Peter M Irving, Christian Philipp Selinger, Geert R A M D'Haens, Tanja Kuehbacher, Ursula E Seidler, Savion Gropper, Thomas Haeufel, Sebastiano Forgia, Silvio Danese, Jochen Klaus, Brian G Feagan
Safety and tolerability of spesolimab in patients with ulcerative colitis. Expert opinion on drug safety (2022)
A Barney Hawthorne, Jackie Glatter, Jonathan Blackwell, Rachel Ainley, Ian Arnott, Kevin J Barrett, Graham Bell, Matthew James Brookes, Melissa Fletcher, Rafeeq Muhammed, Alan Michael Nevill, Jonathan P Segal, Christian Philipp Selinger, Anja St Clair Jones, Lisa Younge, null null, Christopher Andrew Lamb
Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patients. Alimentary pharmacology & therapeutics 56 (4) (2022)
Simeng Lin, Neil Chanchlani, Isabel Carbery, Malik Janjua, Rachel Nice, Timothy James McDonald, Claire M Bewshea, Nicholas Alexander Kennedy, Tariq Ahmad, Christian Philipp Selinger, James R Goodhand, null null
Understanding anti-TNF treatment failure: does serum triiodothyronine-to-thyroxine (T3/T4) ratio predict therapeutic outcome to anti-TNF therapies in biologic-naïve patients with active luminal Crohn's disease? Alimentary pharmacology & therapeutics 56 (5) (2022)
Robyn Laube, Eleanor Liu, Ying Li, Rupert W L Leong, Jimmy K Limdi, Christian Philipp Selinger
Gastroenterology team members' knowledge and practices with fertility therapy for women with inflammatory bowel disease. Therapeutic advances in gastroenterology 15 (2022)
Konstantina Rosiou, Jenelyn Carbonell, Vivien Dolby, Niloufar Monfared, Tim Raine, Christian Philipp Selinger
Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: The Leeds IBD Steroids study. Alimentary pharmacology & therapeutics 56 (3) (2022)
Jessica Lovatt, Christian Philipp Selinger
Editorial: choosing the optimal screening method for latent TB in patients with IBD commencing anti-TNF therapy. Alimentary pharmacology & therapeutics 55 (10) (2022)
Christian Philipp Selinger, Marco Vincenzo Lenti, Annalisa De Silvestri
Letter: potential selection bias in real-world comparison of ustekinumab versus vedolizumab as a second-line treatment for Crohn's disease-authors' reply. Alimentary pharmacology & therapeutics 55 (8) (2022)
Gillian Lever, Hlupekile Chipeta, Tracey Glanville, Christian Philipp Selinger
Risk of Adverse Pregnancy Outcomes for Women with IBD in an Expert IBD Antenatal Clinic. Journal of clinical medicine 11 (10) (2022)
Joanna Torres, María Chaparro, Mette Julsgaard, Konstantinos Katsanos, Zuzana Zelinkova, Manasi Agrawal, Sandro Ardizzone, Marjo J E Campmans-Kuijpers, Gabriele Dragoni, Marc Ferrante, Gionata Fiorino, Emma K Flanagan, Catarina Geraldes de Frias Gomes, Ailsa Hart, Charlotte Rose Hedin, Pascal Juillerat, Annemarie Mulders, Pär Myrelid, Aoibhlinn O'Toole, Pauline Riviere, Michael Scharl, Christian Philipp Selinger, Elena Sonnenberg, Murat Toruner, Jantien Wieringa, C Janneke Van der Woude
European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. Journal of Crohn's & colitis (2022)
Gillian Lever, Hlupe Chipeta, Tracey Glanville, Christian Philipp Selinger
Perineal outcomes after delivery in 179 mothers with IBD compared to 31,258 controls - a single centre cohort study. Journal of Crohn's & colitis (2021)
William M Brindle, Rebecca K Grant, Marianne Smith, Meghan Suddaby, Angus Wallace, Sarah-Louise Gillespie, Nicholas I Church, Colin L Noble, Ian D Penman, John N Plevris, Alexander R Robertson, Eleanor F Watson, Christian Philipp Selinger, Rahul Kalla, Gail S M Masterton, null null
Risk stratifying gastric ulcers: development and validation of a scoring system. Frontline gastroenterology 13 (2) (2021)
Christian Philipp Selinger, Aileen Fraser, Paul Collins, Melanie Gunn, Thean Soon Chew, Georgina Kerry, Kamal V Patel, Maya Roysam, Klaartje Bel Kok, Aaron Bancil, Veronica Hall, Rachel Cooney, Lyn Smith, Helen Steed, Jonathan Segal, Alexandra Kent, Jimmy Limdi, Shaji Sebastian
Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD. BMJ open gastroenterology 8 (1) (2021)
Jessica Lovatt, Deborah Gascoyne-Binzi, Thomas Hussey, Maya Garside, Fiona McGill, Christian Philipp Selinger
Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON® Gold Testing Useful? Journal of clinical medicine 10 (9) (2021)
Laurent Goessens, Jean-Frédéric Colombel, An Outtier, Marc Ferrante, Joao Sabino, Ciaran Judge, Reza Saeidi, Louise Rabbitt, Alessandro Armuzzi, Eugeni Domènech, George Michalopoulos, Anneline Cremer, Francisco Javier García-Alonso, Tamas Molnar, Konstantinos Karmiris, Krisztina Gecse, Joep Van Oostrom, Mark Löwenberg, Klaudia Farkas, Raja Atreya, Davide Giuseppe Ribaldone, Christian Philipp Selinger, Frank Hoentjen, Benoit Bihin, Shaji Sebastian, null null, Jean-François Rahier
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study. United European gastroenterology journal (2021)
Marco Vincenzo Lenti, Vivien Dolby, Tanya Clark, Veronica Hall, Suzanne Tattersall, Francesca Fairhurst, Catherine Kenneth, Rachael Walker, Karen Kemp, Simon Borg-Bartolo, Jimmy K Limdi, Jo Taylor, Tristan Townsend, Sree Subramanian, Daniel Storey, Arash Assadsangabi, Catherine Stansfield, Paul Smith, Debra Byrne, Annalisa De Silvestri, Christian Philipp Selinger
A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II. Alimentary pharmacology & therapeutics 55 (7) (2021)
Isabel Carbery, Christian Philipp Selinger
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Alimentary pharmacology & therapeutics 53 (2) (2021)
Nicholas Alexander Kennedy, James R Goodhand, Claire M Bewshea, Rachel Nice, Desmond Chee, Simeng Lin, Neil Chanchlani, Jeffrey Butterworth, Rachel Cooney, Nicholas M Croft, Ailsa L Hart, Peter M Irving, Klaartje B Kok, Christopher Andrew Lamb, Jimmy K Limdi, Jonathan Macdonald, Dermot P B McGovern, Shameer J Mehta, Charles D R Murray, Kamal V Patel, Richard C G Pollok, Timothy Raine, Richard Kay Russell, Christian Philipp Selinger, Philip J Smith, Jack Bowden, Timothy James McDonald, Charlie W Lees, Shaji Sebastian, Nicholas Powell, Tariq Ahmad, null null
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut 70 (5) (2021)
Robyn Laube, Christian Philipp Selinger
Editorial: standardising inclusion and outcome criteria for pouchitis-a fragile consensus perhaps but a first step in the right direction. Alimentary pharmacology & therapeutics 53 (10) (2021)
Konstantina Rosiou, Elaine Ong Ming San, Aditi Kumar, Kim Esquivel, Saima Almas, Daniel Stokes, Tze Ng, Nishani Jayasooriya, Ian Ranasinghe, Richard Pollok, Matthew James Brookes, Christian Philipp Selinger
Comparative Outcomes of Budesonide MMX versus Prednisolone for Ulcerative Colitis: Results from a British Retrospective Multi-Centre Real-World Study. Journal of clinical medicine 10 (19) (2021)
Deepa Denesh, Jenelyn Carbonell, John S Kane, David Gracie, Christian Philipp Selinger
Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration. Expert review of gastroenterology & hepatology 15 (9) (2021)
Konstantina Rosiou, Christian Philipp Selinger
Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians. Internal and emergency medicine 16 (6) (2021)
Nicholas Alexander Kennedy, Gareth-Rhys Jones, Christopher Andrew Lamb, Richard Appleby, Ian Arnott, Robert Mark Beattie, Stuart Bloom, Alenka J Brooks, Rachel Cooney, Robin John Dart, Cathryn M Edwards, Aileen Fraser, Daniel R Gaya, Subrata Ghosh, Kay Greveson, Richard Hansen, Ailsa L Hart, A Barney Hawthorne, Bu' Hussain Hayee, Jimmy K Limdi, Charles D R Murray, Gareth C Parkes, Miles Parkes, Kamal Patel, Richard C G Pollok, Nicholas Powell, Chris S Probert, Timothy Raine, Shaji Sebastian, Christian Philipp Selinger, Philip J Smith, Catherine Stansfield, Lisa Younge, James O Lindsay, Peter M Irving, Charlie W Lees
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut 69 (6) (2020)
Robyn Laube, Christian Philipp Selinger
Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medications. Alimentary pharmacology & therapeutics 51 (9) (2020)
Rovshan M Ismailov, Lieven Pouillon, Christian Philipp Selinger, Zaytuna D Khasanova
Knowledge and awareness of biosimilars and shared decision-making among gastroenterology team members in Colorado, USA. Expert opinion on biological therapy 21 (1) (2020)
Christian Philipp Selinger, Nicola Carey, Shelley Cassere, Catherine Nelson-Piercy, Aileen Fraser, Veronica Hall, Kate Harding, Jimmy Limdi, Lyn Smith, Marie Smith, Melanie Catherine Gunn, Aarthi Mohan, Khasia Mulgabal, Alexandra Kent, Klaartje Bel Kok, Tracey Glanville
Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine Society. Frontline gastroenterology 12 (3) (2020)
Christian Philipp Selinger, Catherine Nelson-Piercy, Aileen Fraser, Veronica Hall, Jimmy Limdi, Lyn Smith, Marie Smith, Reem Nasur, Melanie Gunn, Andrew King, Aarthi Mohan, Khasia Mulgabal, Alexandra Kent, Klaartje Bel Kok, Tracey Glanville
IBD in pregnancy: recent advances, practical management. Frontline gastroenterology 12 (3) (2020)
Jessica Lovatt, Christian Philipp Selinger
Letter: recognising frailty in patients with inflammatory bowel disease is crucial for appropriate personalised treatment. Alimentary pharmacology & therapeutics 52 (5) (2020)
Sarah Wolloff, Emma Moore, Tracey Glanville, Jimmy Limdi, Klaartje B Kok, Aileen Fraser, Alexandra Kent, Khasia Mulgabal, Catherine Nelson-Piercy, Christian Philipp Selinger
Provision of care for pregnant women with IBD in the UK: the current landscape. Frontline gastroenterology 12 (6) (2020)
Christian Philipp Selinger
Letter: increased risk of caesarean section for women with IBD-more questions than answers. Alimentary pharmacology & therapeutics 51 (6) (2020)
Eve Braithwaite, Jenelyn Carbonell, John S Kane, David Gracie, Christian Philipp Selinger
Patients' perception of colonoscopy and acceptance of colonoscopy based IBD related colorectal cancer surveillance. Expert review of gastroenterology & hepatology 15 (2) (2020)
Shahida Din, Alexandra J Kent, Richard C G Pollok, Susanna Meade, Nicholas Alexander Kennedy, Ian Arnott, Robert Mark Beattie, Felix Chua, Rachel Cooney, Robin John Dart, James B Galloway, Daniel R Gaya, Subrata Ghosh, Mark J D Griffiths, Laura Hancock, Richard Hansen, Ailsa L Hart, Christopher Andrew Lamb, Charlie W Lees, Jimmy K Limdi, James O Lindsay, Kamal V Patel, Nicholas Powell, Charles D R Murray, Chris S Probert, Timothy Raine, Christian Philipp Selinger, Shaji Sebastian, Philip J Smith, Phillip Tozer, Andrew Ustianowski, Lisa Younge, Mark A Samaan, Peter M Irving
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. Gut 69 (10) (2020)
Christian Philipp Selinger, Jenelyn Carbonell, John S Kane, Mandour Omer, Alexander Charles Ford
Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission. Frontline gastroenterology 12 (1) (2020)
Christian Philipp Selinger, Helen Rafferty, Peter Mooney, Clare Donnellan
Utility of Fecal Calprotectin in Routine Clinical Practice Is Impaired by Poor Sample Return Rates. Digestive diseases and sciences 66 (9) (2020)
Christian Philipp Selinger, Gareth C Parkes, Ash Bassi, Jimmy K Limdi, Helen Ludlow, Pritash Patel, Melissa Smith, Santosh Saluke, Zandile Ndlovu, Becky George, John Saunders, Mark Adamson, Aileen Fraser, Jenna Robinson, Fiona Donovan, Ioanna Parisi, Jude Tidbury, Lynn Gray, Richard Pollok, Glyn Scott, Tim Raine
Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients. Alimentary pharmacology & therapeutics 50 (9) (2019)
Christopher Andrew Lamb, Nicholas Alexander Kennedy, Timothy Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu' Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Philipp Selinger, Kevin J Barrett, Richard Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy D Sanderson, Helen Terry, null null, Daniel R Gaya, Tariq H Iqbal, Stuart Andrew Taylor, Melissa Smith, Matthew James Brookes, Richard Hansen, A Barney Hawthorne
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68 (Suppl 3) (2019)
Chui Chong, Anisha Rahman, Khaleel Loonat, Rebecca C Sagar, Christian Philipp Selinger
Current smoking habits in British IBD patients in the age of e-cigarettes. BMJ open gastroenterology 6 (1) (2019)
Jihane Ghorayeb, Peter Branney, Christian Philipp Selinger, Anna Madill
When Your Pregnancy Echoes Your Illness: Transition to Motherhood With Inflammatory Bowel Disease. Qualitative health research 28 (8) (2018)
Satvinder Purewal, Sarah Chapman, Wladyslawa Czuber-Dochan, Christian Philipp Selinger, Helen Steed, Matthew James Brookes
Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients' reproductive health. Alimentary pharmacology & therapeutics 48 (11-12) (2018)
Christian Philipp Selinger, G C Parkes, T Raine
Editorial: avoiding corticosteroids in the treatment of inflammatory bowel disease-Author's reply. Alimentary pharmacology & therapeutics 47 (1) (2017)
Christian Philipp Selinger, G C Parkes, A Bassi, E Fogden, B Hayee, J K Limdi, H Ludlow, S McLaughlin, P Patel, M Smith, T Raine
A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 46 (10) (2017)